Stockreport

Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For example, the Halozyme Therapeutics, Inc. NASDAQ: [Read more]